Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Injectable, Drug-Eluting Nanocrystals Prevent Fibrosis and Stricture Formation In Vivo.
Li L, Shapiro RL, Joo MK, Josyula A, Hsueh HT, Gutierrez OB, Halpert G, Akshintala V, Chen H, Curtis S, Better M, Davison C, Hu H, Almario JAN, Steinway SN, Hunt K, Del Sesto RE, Izzi J, Salimian KJ, Ensign LM, Selaru FM. Li L, et al. Among authors: better m. Gastroenterology. 2023 May;164(6):937-952.e13. doi: 10.1053/j.gastro.2023.01.006. Epub 2023 Jan 16. Gastroenterology. 2023. PMID: 36657529 Free PMC article.
In vitro and ex vivo models for evaluating vaginal drug delivery systems.
Shapiro RL, DeLong K, Zulfiqar F, Carter D, Better M, Ensign LM. Shapiro RL, et al. Among authors: better m. Adv Drug Deliv Rev. 2022 Dec;191:114543. doi: 10.1016/j.addr.2022.114543. Epub 2022 Oct 5. Adv Drug Deliv Rev. 2022. PMID: 36208729 Free PMC article. Review.
Nanomedicine for Maternal and Fetal Health.
Carter D, Better M, Abbasi S, Zulfiqar F, Shapiro R, Ensign LM. Carter D, et al. Among authors: better m. Small. 2023 Oct 10:e2303682. doi: 10.1002/smll.202303682. Online ahead of print. Small. 2023. PMID: 37817368 Review.
Accelerating the development of genetically engineered cellular therapies: a framework for extrapolating data across related products.
Stewart MD, Kalos M, Coutinho V, Better M, Jazayeri J, Yohrling J, Jadlowsky J, Fuchs M, Gidwani S, Goessl C, Hanley PJ, Healy J, Liu W, McKelvey BA, Pearce L, Pilon-Thomas S, Andrews HS, Veldman M, Vong J, Weinbach SP, Allen JD. Stewart MD, et al. Among authors: better m. Cytotherapy. 2024 Mar 16:S1465-3249(24)00097-5. doi: 10.1016/j.jcyt.2024.03.009. Online ahead of print. Cytotherapy. 2024. PMID: 38583170 Free article.
Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma.
Locke FL, Rossi JM, Neelapu SS, Jacobson CA, Miklos DB, Ghobadi A, Oluwole OO, Reagan PM, Lekakis LJ, Lin Y, Sherman M, Better M, Go WY, Wiezorek JS, Xue A, Bot A. Locke FL, et al. Among authors: better m. Blood Adv. 2020 Oct 13;4(19):4898-4911. doi: 10.1182/bloodadvances.2020002394. Blood Adv. 2020. PMID: 33035333 Free PMC article.
T cell-targeted immunofusion proteins from Escherichia coli.
Better M, Bernhard SL, Williams RE, Leigh SD, Bauer RJ, Kung AH, Carroll SF, Fishwild DM. Better M, et al. J Biol Chem. 1995 Jun 23;270(25):14951-7. doi: 10.1074/jbc.270.25.14951. J Biol Chem. 1995. PMID: 7541032 Free article.
34 results